Table 1.
r-FSH +hp-hMG (Group I) | hp-hMG (Group II) | Fixed-dose r-FSH (Group III) | r-FSH dose-adjusted (Group IV) | |
---|---|---|---|---|
Patient age (years) | 31.27 ± 2.83 | 32.39 ± 2.70 | 33.72 ± 3.33 | 33.19 ± 3.17 |
Partner age (years) | 33.72 ± 4.54 | 35.94 ± 4.27 | 36.23 ± 4.68 | 35.74 ± 5.09 |
Years of sterility | 4.69 ± 1.45 | 5.04 ± 2.14 | 5.75 ± 2.94 | 5.49 ± 2.54 |
BMI (kg/m2) | 21.87 ± 2.32 | 22.34 ± 2.62 | 22.61 ± 2.66 | 23.45 ± 2.83 |
First cycle | 42 (84%) | 43 (70.5%) | 72 (61%) | 54 (72%) |
Baseline FSH (mIU/mL) | 6.12 ± 1.30 | 5.92 ± 1.47 | 6.42 ± 1.53 | 6.17 ± 1.21 |
Baseline LH (mIU/mL) | 4.56 ± 1.73 | 5.28 ± 2.74 | 5.20 ± 2.22 | 4.76 ± 1.85 |
Prolactin (ng/mL) | 21.16 ± 9.73 | 21.76 ± 12.44 | 20.09 ± 11.42 | 17.98 ± 7.86 |
Baseline testosterone (ng/mL) | 0.52 ± 0.23 | 0.49 ± 0.22 | 0.48 ± 0.14 | 0.62 ± 0.39 |
Baseline progesterone (pg/mL) | 7.10 (4.40 ± 11.20) | 5.85 (4.35 ± 8.40) | 8.30 (5.70 ± 13.00) | 9.60 (7.80 ± 17.00) |
Note: Data are given as the mean (standard deviation) or frequency (%).
Abbreviations: r-FSH, recombinant FSH; hp-hMG, highly purified hMG.